Portola strikes royalty deal for AndexXa

Portola Pharmaceuticals Inc. (NASDAQ:PTLA) sold mid-single digit royalties on AndexXa andexanet alfa to HealthCare Royalty Partners (Stamford, Conn.)

Read the full 182 word article

User Sign In